eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapiesLise Boussemart, Stéphan Vagner, Oskar Hemmingsson et al.|Nature|2014Cited by 361
Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanomaMichaël Cerezo, Caroline Robert, Ramdane Guemiri et al.|Nature Medicine|2018Cited by 265